Similar to these findings, a previous study reported that benign prostate specimens expressed high levels of BMPR1A; however, prostate-cancer specimens expressed much lower levels of BMPR1A, which suggests that loss of BMPR1A may play a vital role during the progression of prostate cancer [15]. The gene discussed is BMPR1A; the disease is prostate carcinoma.